C-Reactive Protein Gene Variants and Their Serum Levels in Early Adult-onset Type 2 Diabetes Mellitus

Overview

Journal In Vivo

Specialty Oncology

Date 2019 Sep 1

PMID 31471424

Citations 4

Authors

Yu-Chuen Huang

Ching-Chu Chen

Tzu-Yuan Wang

Hung Tran The Nguyen

Yung-Hsiang Chen

Chia-Ming Wu

Ya-Wen Chang

Wen-Ling Liao

Fuu-Jen Tsai

Affiliations

Soon will be listed here.

Abstract

Background/aim: C-Reactive protein (CRP) is a common marker of inflammation. Elevated CRP levels have been associated with increased risk of development of type 2 diabetes mellitus (T2DM). This study aimed to evaluate the association of CRP gene polymorphisms with early-onset T2DM and the effect of genetic variants on CRP level.

Materials And Methods: In total, 948 individuals with early-onset (n=271) or late-onset (n=677) T2DM were enrolled in the study. Five single-nucleotide polymorphisms (SNPs) in the CRP gene, namely rs3093077, rs2808630, rs1800947, rs11265263, and rs11265265, were selected for genotyping, and CRP levels were measured.

Results: Genotypic, allelic, and haplotype frequencies of these five SNPs were not significantly different between patients with early- and those with late-onset. T2DM Higher serum CRP levels were independently associated with the C-allele of rs3093077 and T-allele of rs11265265 (p<0.001). Furthermore, the C-allele of rs3093077 was associated with higher CRP level in both early- (p=0.016) and late-onset (p<0.001) T2DM.

Conclusion: CRP gene variants may contribute to the risk of early-onset T2DM by affecting the serum CRP level.

Citing Articles

Haplotype analysis on association between C-reactive protein gene and susceptibility to type 2 diabetes mellitus in Chinese Han population : CRP gene and type 2 diabetes mellitus.

Luo W, Qiang D, Zhu W, Kong X, Xu W Acta Diabetol. 2024; 61(11):1423-1432.

PMID: 38833006 DOI: 10.1007/s00592-024-02309-x.

Age at Diagnosis of Diabetes in Young Men is Associated with Albuminuria.

Zhang Q, Cheng L, Li B, Lu Y, Yang S, Wu Y Diabetes Metab Syndr Obes. 2024; 17:1543-1549.

PMID: 38596197 PMC: 11001537. DOI: 10.2147/DMSO.S454867.

The Clinical Values of Afamin, Triglyceride and PLR in Predicting Risk of Gestational Diabetes During Early Pregnancy.

Wang X, Zheng X, Yan J, Xu R, Xu M, Zheng L Front Endocrinol (Lausanne). 2021; 12:723650.

PMID: 34803906 PMC: 8597949. DOI: 10.3389/fendo.2021.723650.

C-Reactive Protein +1444C/T Polymorphism Is Associated with the Susceptibility to Pulmonary Tuberculosis.

Xu Y, Cheng M, Wang X Biomed Res Int. 2021; 2020:6634879.

PMID: 33415152 PMC: 7769630. DOI: 10.1155/2020/6634879.

References

Kathiresan S, Larson M, Vasan R, Guo C, Gona P, Keaney Jr J . Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation. 2006; 113(11):1415-23. DOI: 10.1161/CIRCULATIONAHA.105.591271. View

Xiang K, Wang Y, Zheng T, Jia W, Li J, Chen L . Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes. 2003; 53(1):228-34. DOI: 10.2337/diabetes.53.1.228. View

Pfutzner A, Schondorf T, Hanefeld M, Forst T . High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone. J Diabetes Sci Technol. 2010; 4(3):706-16. PMC: 2901049. DOI: 10.1177/193229681000400326. View

Pfutzner A, Standl E, Strotmann H, Schulze J, Hohberg C, Lubben G . Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clin Chem Lab Med. 2006; 44(5):556-60. DOI: 10.1515/CCLM.2006.108. View

Liao W, Chen C, Chang C, Wu J, Chen C, Huang Y . Gene polymorphisms of adiponectin and leptin receptor are associated with early onset of type 2 diabetes mellitus in the Taiwanese population. Int J Obes (Lond). 2011; 36(6):790-6. DOI: 10.1038/ijo.2011.174. View

Bassuk S, Manson J . Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol (1985). 2005; 99(3):1193-204. DOI: 10.1152/japplphysiol.00160.2005. View

Lango H, Palmer C, Morris A, Zeggini E, Hattersley A, McCarthy M . Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes. 2008; 57(11):3129-35. PMC: 2570411. DOI: 10.2337/db08-0504. View

Zacho J, Tybjaerg-Hansen A, Skov Jensen J, Grande P, Sillesen H, Nordestgaard B . Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008; 359(18):1897-908. DOI: 10.1056/NEJMoa0707402. View

Shield J, Lynn R, Wan K, Haines L, Barrett T . Management and 1 year outcome for UK children with type 2 diabetes. Arch Dis Child. 2008; 94(3):206-9. DOI: 10.1136/adc.2008.143313. View

10.

Mugabo Y, Li L, Renier G . The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev. 2009; 6(1):27-34. DOI: 10.2174/157339910790442628. View

11.

Badawi A, Klip A, Haddad P, Cole D, Bailo B, El-Sohemy A . Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes. 2011; 3:173-86. PMC: 3047967. DOI: 10.2147/dmsott.s9089. View

12.

Ng M, So W, Cox N, Lam V, Cockram C, Critchley J . Genome-wide scan for type 2 diabetes loci in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes. 2004; 53(6):1609-13. DOI: 10.2337/diabetes.53.6.1609. View

13.

Anan F, Takahashi N, Nakagawa M, Ooie T, Saikawa T, Yoshimatsu H . High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism. 2005; 54(4):552-8. DOI: 10.1016/j.metabol.2004.11.012. View

14.

Chou H, Hsu L, Liu C, Teng M, Wu S, Ko Y . Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese. Metabolism. 2009; 59(6):824-30. DOI: 10.1016/j.metabol.2009.09.030. View

15.

Chang C, Shau W, Jiang Y, Li H, Chang T, Sheu W . Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med. 2010; 27(6):636-43. DOI: 10.1111/j.1464-5491.2010.03007.x. View

16.

Ottaviani S, Gorrini M, Scabini R, Kadija Z, Paracchini E, Mariani F . C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. Transl Res. 2011; 157(6):332-8. DOI: 10.1016/j.trsl.2010.12.014. View

17.

Wolford J, Gruber J, Ossowski V, Vozarova B, Tataranni P, Bogardus C . A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab. 2003; 78(2):136-44. DOI: 10.1016/s1096-7192(02)00230-5. View

18.

Teng M, Hsu L, Wu S, Chang H, Chou H, Ko Y . Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwanese: interaction with obesity. Atherosclerosis. 2008; 204(2):e64-9. DOI: 10.1016/j.atherosclerosis.2008.10.034. View

19.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012; 36 Suppl 1:S67-74. PMC: 3537273. DOI: 10.2337/dc13-S067. View

20.

Koopman R, Mainous 3rd A, Diaz V, Geesey M . Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med. 2005; 3(1):60-3. PMC: 1466782. DOI: 10.1370/afm.214. View